Yuki Ishibashi

Showing 1-8 of 8 articles

Coronary interventions

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys P, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein AP, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study

Nakatani S, Onuma Y, Ishibashi Y, Karanasos A, Regar E, Garcia-Garcia H, Tamburino C, Fajadet J, Vrolix M, Witzenbichler B, Eeckhout E, Spaulding C, Reczuch K, La Manna A, Spaargaren R, Capodanno D, van Langenhove G, Verheye S, Serruys P, van Geuns R

December 20, 2015 | 10.4244/EIJY15M11_01

Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients

Ishibashi Y, Nakatani S, Onuma Y

July 20, 2015 | 10.4244/EIJY14M09_08

Coronary interventions

The need for dedicated bifurcation quantitative coronary angiography (QCA) software algorithms to evaluate bifurcation lesions

Grundeken M.J, Ishibashi Y, Ramcharitar S, Tuinenburg J, Reiber J, Tu S, Aben J-P, Girasis C, Wykrzykowska J, Onuma Y, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA10

Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial

Nakatani S, Onuma Y, Ishibashi Y, Muramatsu T, Iqbal J, Zhang Y-J, van Geuns R, Ormiston J, Serruys P

March 20, 2015 | 10.4244/EIJV10I11A218

Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve

Papafaklis M, Muramatsu T, Ishibashi Y, Lakkas L, Nakatani S, Bourantas C, Ligthart J, Onuma Y, Echavarría-Pinto M, Tsirka G, Kotsia A, Nikas D, Mogabgab O, van Geuns R, Naka K, Fotiadis D, Brilakis E, Garcia-Garcia H, Escaned J, Zijlstra F, Michalis L, Serruys P

September 28, 2014 | 10.4244/EIJY14M07_01

Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial

Ishibashi Y, Onuma Y, Muramatsu T, Nakatani S, Iqbal J, Garcia-Garcia H, Bartorelli A, Whitbourn R, Abizaid A, Serruys P

August 19, 2014 | 10.4244/EIJV10I4A78

1

Latest news

Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure

Ahead of print: New technique of percutaneous mitral valvuloplasty

C. Aurigemma et al

Rotational atherectomy and the myth of Sisyphus

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Fractional flow reserve substitutes in aortic stenosis

Nils P. Johnson

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease